Last Updated:
Name Designation Appointment Date Status
Kalpana Ashutosh Pudage

Appointed as Director since June 2024

Director 19-Jun-2024 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Ashutosh Madhusudan Pudage

Appointed as Director since June 2024

Director 19-Jun-2024 Current
Sagar Pratap Sarode

Appointed as Director since November 2024

Director 05-Nov-2024 Current

People Timeline

Explore the timeline of key personnel in Kaas Biopharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address Flat 201 Plot 64, Yash Ente Sector 14, Thane Maharashtra, 400709, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400709
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Kaas Biopharma Private Limited?
You can contact Kaas Biopharma Private Limited through their registered address at Flat 201 Plot 64, Yash Ente Sector 14, Thane Maharashtra, 400709, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Kaas Biopharma Private Limited?
The current directors of Kaas Biopharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Kalpana Ashutosh Pudage
  • Ashutosh Madhusudan Pudage
  • Sagar Pratap Sarode
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available